首页> 美国政府科技报告 >Reregistration Eligibility Document (RED) Hydroxytetracycline Monohydrochlorideand Oxytetracycline Calcium
【24h】

Reregistration Eligibility Document (RED) Hydroxytetracycline Monohydrochlorideand Oxytetracycline Calcium

机译:重新注册资格文件(RED)羟基四环素单盐酸盐和土霉素钙

获取原文

摘要

The Reregistration Eligibility Document (RED) will address the eligibility forreregistration of products containing hydroxytetracycline monohydrochloride and oxytetracycline calcium. Oxytetracycline is an antibiotic drug produced by the actinomycete Streptomyces rimosus. It is also registered to prevent the growth of, or control bacterial and fungi diseases and mycoplasmalike organisms in nectarines, peaches, pears, coconut and pritchardia palms and as an antifoulant added to paint to prevent the growth of barnacles. There are registered products containing hydroxytetracycline monohydrochloride and oxytetracycline calcium, but none with oxytetracycline, per se. Therefore, the Reregistration Eligibility Document (RED) addresses only oxytetracycline calcium and hydroxytetracycline monohydrochloride, even though some of the studies supporting the RED decision were conducted with the oxytetracycline base.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号